Stephanie Shiau1, Stephen M Arpadi2, Michael T Yin3. 1. Department of Biostatistics and Epidemiology, Rutgers School of Public Health, 683 Hoes Lane West, Piscataway, NJ, 08854, USA. 2. G.H. Sergievsky Center and Department of Pediatrics, Vagelos College of Physicians & Surgeons, Columbia University Irving Medical Center, 622 West 168th Street, New York, NY, 10032, USA. 3. Division of Infectious Diseases, Department of Medicine, Vagelos College of Physicians & Surgeons, Columbia University Irving Medical Center, 622 West 168th Street, New York, NY, 10032, USA. mty4@cumc.columbia.edu.
Abstract
PURPOSE OF REVIEW: In the era of modern bone-friendly antiretroviral therapy (ART) regimens for people living with HIV (PLWH), this review discusses the research gaps and management concerns that remain for individuals who have already been exposed to ART with negative effects on bone metabolism, especially children and adolescents who have not acquired peak bone mass, and older adults who have additional risk factors for fracture. RECENT FINDINGS: Data now support the use of avoidance of TDF and use of bone-friendly regimens that include integrase strand transfer inhibitors in PLWH with increased risk of fracture for either ART initiation or switch. Despite significant advances in our understanding of ART choice for PLWH with regard to bone health, additional diagnostic tests to determine fracture risk and management strategies beyond ART choice are necessary, especially in vulnerable PLWH populations, such as children and adolescents and older adults.
PURPOSE OF REVIEW: In the era of modern bone-friendly antiretroviral therapy (ART) regimens for people living with HIV (PLWH), this review discusses the research gaps and management concerns that remain for individuals who have already been exposed to ART with negative effects on bone metabolism, especially children and adolescents who have not acquired peak bone mass, and older adults who have additional risk factors for fracture. RECENT FINDINGS: Data now support the use of avoidance of TDF and use of bone-friendly regimens that include integrase strand transfer inhibitors in PLWH with increased risk of fracture for either ART initiation or switch. Despite significant advances in our understanding of ART choice for PLWH with regard to bone health, additional diagnostic tests to determine fracture risk and management strategies beyond ART choice are necessary, especially in vulnerable PLWH populations, such as children and adolescents and older adults.
Entities:
Keywords:
Bone mineral density; Fracture; Osteoporosis
Authors: Beatriz Jiménez; Talía Sainz; Laura Díaz; María José Mellado; María Luisa Navarro; Pablo Rojo; María Isabel González-Tomé; Luis Prieto; Jorge Martínez; María Isabel de José; José Tomás Ramos; María Ángeles Muñoz-Fernandez Journal: Pediatr Infect Dis J Date: 2017-06 Impact factor: 2.129
Authors: Stephen M Arpadi; Cara B Thurman; Faeezah Patel; Jonathan J Kaufman; Renate Strehlau; Megan Burke; Stephanie Shiau; Ashraf Coovadia; Michael T Yin Journal: J Pediatr Date: 2019-08-29 Impact factor: 4.406
Authors: Aylin B Unsal; Aviva S Mattingly; Sara E Jones; Julia B Purdy; James C Reynolds; Jeffrey B Kopp; Rohan Hazra; Colleen M Hadigan Journal: J Clin Endocrinol Metab Date: 2017-08-01 Impact factor: 5.958
Authors: Todd T Brown; Carlee Moser; Judith S Currier; Heather J Ribaudo; Jennifer Rothenberg; Theodoros Kelesidis; Otto Yang; Michael P Dubé; Robert L Murphy; James H Stein; Grace A McComsey Journal: J Infect Dis Date: 2015-05-05 Impact factor: 5.226
Authors: Peter L Havens; Charles B Stephensen; Marta D Van Loan; Gertrud U Schuster; Leslie R Woodhouse; Patricia M Flynn; Catherine M Gordon; Cynthia G Pan; Brandy Rutledge; Nancy Liu; Craig M Wilson; Rohan Hazra; Sybil G Hosek; Peter L Anderson; Sharon M Seifert; Bill G Kapogiannis; Kathleen Mulligan Journal: Clin Infect Dis Date: 2016-11-15 Impact factor: 9.079
Authors: Mark J Bolland; Andrew Grey; Anne M Horne; Simon E Briggs; Mark G Thomas; Rod B Ellis-Pegler; Greg D Gamble; Ian R Reid Journal: J Clin Endocrinol Metab Date: 2012-03-14 Impact factor: 5.958
Authors: Kathleen Mulligan; D Robert Harris; Patricia Emmanuel; Roger A Fielding; Carol Worrell; Bill G Kapogiannis; Dina Monte; John Sleasman; Craig M Wilson; Grace M Aldrovandi Journal: Clin Infect Dis Date: 2012-05-09 Impact factor: 9.079
Authors: Grace A McComsey; Sergio Lupo; David Parks; Mónica Coronado Poggio; Joseph De Wet; Lesley P Kahl; Kostas Angelis; Brian Wynne; Kati Vandermeulen; Martin Gartland; Michael Cupo; Michael Aboud Journal: AIDS Date: 2018-02-20 Impact factor: 4.177
Authors: Michael T Yin; Donald R Hoover; Qiuhu Shi; Phyllis C Tien; Mardge H Cohen; Seble Kassaye; Deborah Gustafson; Adaora Adimora; M Neale Weitzmann; Hector Bolivar; Amy Warriner; Sara H Bares; Anjali Sharma Journal: AIDS Date: 2022-06-22 Impact factor: 4.632
Authors: Arnold Z Olali; Kelsey A Carpenter; Maria Myers; Anjali Sharma; Michael T Yin; Lena Al-Harthi; Ryan D Ross Journal: Curr HIV/AIDS Rep Date: 2022-06-20 Impact factor: 5.495